As Chief Executive Officer and President, Mr. Owen Murray leads Bend Bioscience in its mission to ‘amplify the potential of medicine.’ He is responsible for strategy development and executive function of Bend Bioscience with a passion for scientific value creation. He has over 25 years of experience in the global pharmaceutical and healthcare industry encompassing early product development through commercialization within Innovator and CDMO businesses.

He most recently served as the Chief Executive Officer at Aprecia Pharmaceuticals. Before joining Aprecia, Mr. Murray held varying positions of increasing responsibility at Recordati Rare Diseases, Cardinal Health, Lundbeck, and Ovation Pharmaceuticals in the EU and US.

Mr. Murray received his B.Sc. in Biochemistry with honors from the University of Wales, Swansea. He earned his MBA with a management concentration from Seton Hall University and has an MSc in Healthcare Leadership from Brown University. Mr. Murray holds numerous international patents.

Gwen Green brings a wealth of experience in commercial excellence, strategy, and leadership within the pharmaceutical and biotech sectors.   She is responsible for overseeing sales, marketing, and business development strategies to maximize our market share. Prior to joining Bend Bioscience, Gwen held various leadership positions for Catalent, Cardinal Health, and PCI and has a proven record for driving business growth, cross-functional engagement, and development of employees.

Gwen holds a BS, Nutrition and Science from The Pennsylvania State University and currently serves on the Board of Directors for National Tay Sachs and Allied Diseases Association of Delaware Valley.

Sandra brings over 20 years of progressive leadership experience in Human Resources within the pharmaceutical industry, navigating diverse organizational landscapes, including mergers & acquisitions, unionized environments, startups, and company closures.  She serves as a trusted advisor to the executive team, providing strategic guidance and addressing key organizational challenges. Sandra has served in several key HR leadership roles, including Vice President of Human Resources at SCN BestCo, Senior Director of HR at Societal CDMO (formerly Recro CDMO), and Site HR Manager for Noramco/Janssen Pharmaceuticals.

She holds an MBA in Business Management, Operations and Organizational Behavior from Southern Methodist University, and a BBA in Management and Human Resources from Texas A&M University.

Jacob is an accomplished executive and  a multi-disciplined leader with more than 28 years of experience in manufacturing, quality, program management, research & development, commercial and supply chain all in the pharmaceutical and contract manufacturing industry.  He has played a pivotal role in optimizing  processes, ensuring the timely delivery of high-quality products, and fostering essential relationships with key stakeholders. His leadership has been instrumental in enhancing the overall performance and growth of the organizations he led.  Jacob’s leadership strategy focuses on integrating people, processes, and technology to achieve organizational success. He believes in empowering his team through continuous learning and development, fostering a culture of collaboration and innovation. By leveraging these techniques, Jacob has streamlined operations and improved decision-making processes, resulting in increased efficiency and productivity.

Prior to Bend Jacob had various levels of increasing responsibilities at Abbott Laboratories, and Hospira Inc. and most recently as the Vice President of Supply Chain at Merz Aesthetics

Jacob holds a degree from University Wisconsin – LaCrosse and certifications in Leadership (Harvard Leadership Academy) and Buisnes Management (Lake Forest School of Management).

Dan has greater than 25 years of experience as a global CDMO business leader and drug delivery innovator and has contributed to process and formulation development, particle engineering and materials science innovations resulting in more than 15 patents.  Dan’s experience in the pharma services industry spans manufacturing science and technology, product development, alliance management, corporate development. Prior to joining CoreRx, Dan held leadership roles in Commercial Development at Lonza, Strategic Alliance Management at Capsugel, and as the Vice President of Engineering for Bend Research, Inc.

Dan earned a Bachelor of Sciences degree in Chemical Engineering at Oregon States University.

Rick Schindewolf has more than 35 years of experience in the pharmaceutical and medical device industries, including finance, business development and general management roles at contract development and manufacturing companies.

Rick held leadership roles at Baxter Healthcare, Fisher Scientific, Cardinal Health before transitioning to smaller privately held companies in 2009.

Most recently he served as Chief Financial Officer for SiO2 Material Sciences and prior to that was CFO at Leiters Health, a private equity backed 503B sterile injectable compounding manufacturer sold to Welsh, Carson, Anderson and Stowe in 2021. He also served as Chief Financial Officer for BDI Pharma a privately held mid-sized blood plasma distributor, which was acquired by McKesson Corporation in 2017.

Rick holds a BS in Business Administration from the University of San Diego.

Dan has over 25 years of experience in quality control, quality assurance, operations, OPEX, research & development, both in the pharmaceutical and contract manufacturing industry. Dan’s career began within the laboratory as a development chemist eventually overseeing Quality Control and Analytical Development laboratories at various facilities. Dan has also overseen multiple transformations of Quality Management Systems to support the demanding CDMO model.

Prior to joining Bend Bioscience, Dan held leadership roles within Quality at Catalent Pharma Solutions and Formulated Solutions.Dan earned a Bachelor of Sciences degree in Chemistry at Delaware Valley University. Dan also is a certified LSS Black Belt.